Latest DCPH reports update at 2024-02-07: 2023 ∙ 2022 ∙ 2021

Deciphera Pharmaceuticals DCPH

$ 25.37 0.0%

Deciphera Pharmaceuticals Balance Sheet 2011-2024 | DCPH

Annual Balance Sheet Deciphera Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-57.6 M	-35.6 M	-56.2 M	-	-103 M	-292 M	-195 M	-55.8 M	-23.9 M	-	-	-	-
Long Term Debt	22.4 M	25.9 M	28 M	-	-	1.11 M	1.29 M	1.48 M	1.68 M	-	-	-	-
Long Term Debt Current	3.5 M	3.24 M	2.87 M	2.46 M	1.75 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	15.9 M	12.8 M	1.31 M	194 M	139 M	-	-	-	-
Total Current Liabilities	100 M	86.5 M	96.8 M	70 M	60 M	22.7 M	13.8 M	-	-	-	-	-	-
Total Liabilities	123 M	112 M	125 M	98.8 M	75.9 M	35.6 M	15.1 M	199 M	142 M	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.43 B	-1.23 B	-1.05 B	-754 M	-488 M	-296 M	-196 M	-146 M	-120 M	-	-	-	-
Total Assets	474 M	454 M	429 M	642 M	622 M	316 M	199 M	58.9 M	26.8 M	-	-	-	-
Cash and Cash Equivalents	83.5 M	64.7 M	87.1 M	136 M	120 M	294 M	197 M	57.5 M	25.8 M	-	-	-	-
Book Value	351 M	342 M	305 M	544 M	546 M	280 M	184 M	-140 M	-115 M	-	-	-	-
Total Shareholders Equity	351 M	342 M	305 M	544 M	546 M	280 M	184 M	-140 M	-115 M	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Deciphera Pharmaceuticals

	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	23.3 M	24.2 M	25 M	25.9 M	26.7 M	-	27.2 M	28 M	27.2 M	27.9 M	28.4 M	28.8 M	28.8 M	28.8 M	28.8 M	15.9 M	15.9 M	15.9 M	15.9 M	11.3 M	17.5 M	16.9 M	11.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	116 M	105 M	109 M	112 M	102 M	-	114 M	125 M	103 M	93.9 M	92.2 M	98.8 M	98.8 M	98.8 M	98.8 M	75.9 M	75.9 M	75.9 M	75.9 M	35.6 M	35.6 M	35.6 M	35.6 M	15.1 M	15.1 M	15.1 M	15.1 M	6.04 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.38 B	-1.33 B	-1.28 B	-1.23 B	-1.19 B	-	-1.1 B	-1.05 B	-966 M	-886 M	-816 M	-754 M	-754 M	-754 M	-754 M	-488 M	-488 M	-488 M	-488 M	-296 M	-296 M	-296 M	-296 M	-196 M	-196 M	-196 M	-196 M	-146 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	498 M	510 M	549 M	454 M	476 M	-	385 M	429 M	483 M	541 M	595 M	642 M	642 M	642 M	642 M	622 M	622 M	622 M	622 M	316 M	316 M	316 M	316 M	199 M	199 M	199 M	199 M	58.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	108 M	81.4 M	115 M	64.7 M	82.5 M	110 M	95.3 M	87.1 M	53.2 M	90.9 M	202 M	136 M	136 M	136 M	136 M	120 M	120 M	120 M	120 M	294 M	294 M	294 M	294 M	197 M	197 M	197 M	197 M	57.5 M	-	-	-	25.8 M	-	-	-	770 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	382 M	404 M	440 M	342 M	374 M	-	272 M	305 M	380 M	447 M	503 M	544 M	544 M	544 M	544 M	546 M	546 M	546 M	546 M	280 M	280 M	280 M	280 M	184 M	184 M	184 M	184 M	52.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	382 M	404 M	440 M	342 M	374 M	405 M	272 M	305 M	380 M	447 M	503 M	544 M	544 M	544 M	544 M	546 M	546 M	546 M	546 M	280 M	280 M	280 M	280 M	184 M	184 M	184 M	184 M	-140 M	-	-	-	-115 M	-	-	-	-99.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency